Skip to main content

Advertisement

Log in

Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Our objective was to study relations between non-disclosure of HIV to partner, socio demographics and prevention of HIV mother-to-child transmission (PMTCT), among HIV-infected pregnant women enrolled in the French Perinatal Cohort (ANRS-EPF-CO1) from 2005 to 2009 (N = 2,952). Fifteen percent of the women did not disclose their HIV status to their partner. Non-disclosure was more frequent in women diagnosed with HIV infection late in pregnancy, originating from Sub-Saharan Africa or living alone, as well as when the partner was not tested for HIV. Non-disclosure was independently associated with non optimal PMTCT: late initiation of antiretroviral therapy, detectable viral load at delivery and lack of neonatal prophylaxis. Nonetheless, the rate of transmission did not differ according to disclosure status. Factors associated with non-disclosure reflect vulnerability and its association with non optimal PMTCT is a cause for concern although the impact on transmission was limited in this context of universal free access to care.

Resumen

Nuestro objetivo fue estudiar relaciones entre la no revelación del diagnostico de infección por VIH a la pareja y socio-demográficos factores y prevención de la transmisión madre-niño del VIH (PTMN). Todas las mujeres embarazadas seropositivas que forman parte de la encuesta perinatal francesa (ANRS-EPF-CO1) de 2005 a 2009 fueron incluidas (N = 2,952). Quince por ciento no habían revelado su estatus de VIH a su compañero. La no revelación fue más frecuente en mujeres con un diagnóstico en etapas tardías del embarazo, originarias de África subsahariana o viviendo solas y cuando el compañero no había sido estudiado para el VIH. La no revelación fue asociada independamente a PTMN no óptima: iniciación tardía de la terapia anti-retroviral, carga viral detectable en el parto y ausencia de profilaxis neonatal. Sin embargo, la tasa de transmisión no fue diferente según el estatus de revelación. Factores asociados con la no revelación reflejan vulnerabilidad y su asociación con PTMN no óptima es preocupante aunque con un impacto limitado en un contexto con acceso universal y gratuito al tratamiento.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med. 1994;331(18):1173–80.

    Article  PubMed  CAS  Google Scholar 

  2. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22(2):289–99.

    Article  PubMed  Google Scholar 

  3. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484–94.

    PubMed  CAS  Google Scholar 

  4. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285(16):2083–93.

    Article  PubMed  CAS  Google Scholar 

  5. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458–65.

    Article  Google Scholar 

  6. Newell ML, Huang S, Fiore S, et al. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007;7:60.

    Google Scholar 

  7. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS. 2008;22(8):973–81.

    Article  PubMed  Google Scholar 

  8. Centers for Diseases Control and Prevention. Achievements in public health. Reduction in perinatal transmission of HIV infection–United States, 1985–2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592–7.

  9. Yeni P. Prise en charge médicale des personnes infectées par le VIH. Paris. France: Flammarion Médecine-Sciences; 2008.

  10. Aluisio ABR, Jhon-Stewart G, Mbori-Ngacha D, Farquhar C. Male partner HIV-1 testing and antenatal clinic attendance associated with reduced infant HIV-1 acquisition and mortality. Cap Town: IAS; 2009.

  11. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.

    PubMed  Google Scholar 

  12. Farquhar C, Kiarie JN, Richardson BA, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr. 2004;37(5):1620–6.

    Article  PubMed  Google Scholar 

  13. Sigxaxhe T, Mathews C. Determinants of disclosure by HIV positive women at khayelitsha mother to child transmission pilot project. Durban: International Conference on AIDS Jul 9–14; 2000 .

  14. Antelman G, Smith Fawzi MC, Kaaya S, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001;15:1865–74.

    Article  PubMed  CAS  Google Scholar 

  15. Diagne Gueye NR, Dolfus C, Tabone MD, et al. Psychosocial issues in HIV positive women during the perinatal period. Archives de pédiatrie. 2007;14(5):461–6.

    Article  PubMed  Google Scholar 

  16. Theuring S, Mbezi P, Luvanda H, Jordan-Harder B, Kunz A, Harms G. Male involvement in PMTCT services in Mbeya Region, Tanzania. AIDS Behav. 2009;13(1):92–102.

    Article  PubMed  Google Scholar 

  17. Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS. 2008;22(11):907–16.

    Article  PubMed  Google Scholar 

  18. Brou H, Djohan G, Becquet R, et al. When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. PLoS Med. 2007;4(12):e342.

    Article  PubMed  Google Scholar 

  19. Tubiana R, Matheron S, Le Chenadec J, et al. Extremely low risk of mother-to-child transmission of HIV in women starting HAART before pregnancy in the French perinatal cohort (ANRS EPF CO1/11). Boston: CROI; 2011.

  20. SAS Institute. SAS User’s guide: basics, version 9 edition: Cary: SAS Institute Inc.; 2006.

  21. Forbes KM, Lomax N, Cunningham L, et al. Partner notification in pregnant women with HIV: findings from three inner-city clinics. HIV Med. 2008;9(6):433–5.

    Article  PubMed  CAS  Google Scholar 

  22. Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care. 2006;18(3):254–61.

    Article  PubMed  CAS  Google Scholar 

  23. Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS. 2008;22(12):1503–11.

    Article  PubMed  Google Scholar 

  24. Preau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS. 2007;21(1):S19–27.

    Article  PubMed  Google Scholar 

  25. Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101–8.

    Article  PubMed  Google Scholar 

  26. Wolitski RJ, Pals SL, Kidder DP, Courtenay-Quirk C, Holtgrave DR. The effects of HIV stigma on health, disclosure of HIV status, and risk behaviour of homeless and unstably housed persons living with HIV. AIDS Behav. 2009;13(6):1222–32.

    Article  PubMed  Google Scholar 

  27. Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10(5):483–93.

    Article  PubMed  Google Scholar 

  28. Sherr L, Lampe F, Norwood S, et al. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. AIDS Care. 2008;20(4):442–8.

    Article  PubMed  Google Scholar 

  29. Desgrees du Lou A, Brou H, Djohan G, et al. Beneficial effects of offering prenatal HIV counselling and testing on developing a HIV preventive attitude among couples. Abidjan, 2002–2005. AIDS Behav. 2009;13(2):348–55.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Jasseron.

Additional information

This study was conducted for the ANRS French Perinatal Cohort.

The persons and institutions participated in the ANRS French Perinatal Cohort (EPF) is given in the Appendix.

Appendix

Appendix

The following persons and institutions participated in the ANRS French Perinatal Cohort (EPF):Hôpital Nord, Amiens (Decaux N., Douadi Y., Gondry J., Li Thiao Te V., Schmit J.L.); Hôpital d’Angers (Fournié A.); Hôpital Victor Dupouy, Argenteuil (Allisy C., Brault D.); Hôpital Robert Ballanger, Aulnay (Questiaux E., Zakaria A., Goldenstein C.); Hôpital de Bastia (Pincemaille O.); Hôpital de la Côte Basque, Bayonne (Bonnal F., Cayla C., Hernandorena X.); Hôpital Saint Jacques, Besançon (Estavoyer J.M., Maillet R.); Hôpital Avicenne, Bobigny (Bentata M.); Hôpital Jean Verdier, Bondy (Benoist L., Bolie S., Bonier N., Lachassine E., Rodrigues A.); Hôpital Pellegrin, Bordeaux (Douard D., Roux D., Schaeffer V.); Hôpital Clémenceau, Caen (Beucher G., Brouard J., Goubin P.); Hôpital André Rosemon, Cayenne (Elenga N.); Hôpital de Creil (Carpentier B., Duval-Arnould M., Kingue-Ekollo C.); Hôpital Intercommunal, Créteil (Garrait V., Lemerle S., Pichon C., Richier C., Touboul C.); Hôpital Béclère, Clamart (Bornarel D., Chambrin V., Clech L., Foix L’Hélias L., Labrune P., Schoen H.); Hôpital Louis Mourier, Colombes (Crenn-Hebert C., Floch-Tudal C., Mazy F., Hery E., Meier C.); Hôpital d’enfants, Dijon (Martha S., Reynaud I.); Hôpital Intercommunal, Evreux (Allouche C., Touré K.); Hôpital Francilien Sud, Evry-Corbeil (Chevojon P., Devidas A., Granier M., Marchand C., May A., Nguyen R., Turpault I.); Hôpital de Fontainebleau (Alissa K., Routier C.); Hôpital Victor Fouche, Fort de France (Hatchuel Y., William C.); Hôpital de Lagny (Chalvon Demersay A., Froguel E., Gourdel B., Lanty C.); Hôpital Les Oudairies, La Roche sur Yon (Aubry O., Brossier J.P., Esnault J.L., Leautez S., Perré P., Suaud I.); Hôpital de La Seyne sur Mer (Chamouilli J.M.); Hôpital André Mignot, Le Chesnay (Hentgen V., Messaoudi F.); Hôpital de Bicêtre, Le Kremlin-Bicêtre (Fourcade C.; Fridman S.; Peretti D.); Hôpital Jeanne de Flandres, Lille (D’angelo S., Hammou Y., Mazingue F.); Hôpital de Longjumeau (Bailly-Salin P., Turpault I., Seaume H.); Hôpital Hôtel Dieu-Institut d’hématologie-oncologie pédiatrique, Lyon (Bertrand Y., Brochier C.; Cotte L., Kebaïli K., Tache N., Roussouly MJ., Thoirain V.); Hôpital François Quesnay, Mantes La Jolie (Delanete A., Doumet A., Granier F., Salomon JL.); Hôpital la Conception, Marseille (Cravello L.); Hôpital La Timone Marseille (Thuret I.); Hôpital de Meaux (Karaoui L., Lefèvre V.); Hôpital Marc Jacquet, Melun (Le Lorier B.); Hôpital Intercommunal, Montfermeil (Dehlinger M., Echard M., Mullard C., Talon P.); Hôpital Arnaud de Villeneuve, Montpellier (Benos P., Guigue N., Lalande M.); Hôpital Intercommunal, Montreuil (Heller-Roussin B., Riehl C., Winter C.); Maternité Régionale A. Pinard, Nancy (Hubert C.); Hôpital de Nantes (Brunet-François C., Mechinaud; Reliquet, V.), Hôpital l’Archet-Fondation Lenval, Nice (Bongain A., Deville A., Galiba E., Monpoux F.); Hôpital Caremeau, Nîmes (Dendale-Nguyen J.); Hôpital Orléans (Arsac P., Werner E.); Hôpital d’Orsay (Chanzy S., De Gennes C., Isart V.); Hôpital Bichat, Paris (Bastian H. Bourgeois-Moine A., Matheron S., Rajguru R.); Hôpital Cochin-Port Royal, Paris (Boudjoudi N., Firtion G., Fouchet M., Goupil I., Pannier A.); Hôpital Lariboisière, Paris (Ayral D., Ciraru-Vigneron N., Mouchnino G.); Hôpital Necker, Paris (Boucly S., Blanche S., Maignan A., Parat S., Rouzioux C., Viard,JP., Yamgnane A., Cayol V.); Hôpital Pitié Salpêtrière, Paris (Bonmarchand M., De Montgolfier I., Quetin F., Edeb N., Lemercier D., Harif M., Marcel S., Pauchard M., Tubiana R.); Hôpital Robert Debré, Paris (Faye A., Garion D., Leveille S.; Levine M., Ottenwalter A., Recoules A.); Hôpital Saint-Antoine, Paris (Bui E., Carbonne B., Meyohas M.C., Rodriguez J.); Hôpital Saint Michel, Paris (Aufrant C.); Hôpital Tenon, Paris (Hervé F., Lebrette M.G.); Hôpital Trousseau, Paris (Dollfus C., Tabone M.D., Vaudre G., Wallet A.); Hôpital Marechal Joffre, Perpignan (Bachelard G., Medus M.); Hôpital Les Abymes, Pointe-à-Pitre (Bataille H.); Hôpital René Dubos, Pontoise (Coursol A.); Hôpital Américain, Reims (Munzer M.); Hôpital Charles Nicolle, Rouen (Brossard V.); Hôpital de Saint-Denis (Allemon M.C., Bolot P., Ekoukou D., Ghibaudo N., Gyardeau S., Khuong M.A.); Hôpital Nord, Saint Etienne (Billiemaz K.); Hôpital de Saint Martin (Bissuel F. Walter V.); Hôpital de Haute Pierre-Hôpital Civil, Strasbourg (Cheneau M., Entz-Werle N., Favreau J., Partisani M.); Hôpital Chalucet, Toulon (Hittinger G.); Hôpital Paule de Viguier, Toulouse (Antras M., Armand E., Berrebi A., Tricoire J.) Hôpital Bretonneau, Tours (Besnier J.M., Nau P.); Hôpital Brabois, Vandoeuvre les Nancy (Neimann L.); Hôpital de Villeneuve Saint Georges (Chacé A., Guillot F., Matheron, I.)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jasseron, C., Mandelbrot, L., Dollfus, C. et al. Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission. AIDS Behav 17, 488–497 (2013). https://doi.org/10.1007/s10461-011-0084-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-011-0084-y

Keywords

Navigation